Page last updated: 2024-08-16

temozolomide and ceritinib

temozolomide has been researched along with ceritinib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Alshareef, M; Cachia, D; Das, A; Infinger, LK; Lindhorst, SM; Patel, SJ; Porto, GBF; Vandergrift, WA; Varma, AK1
Honda-Kitahara, M; Ichimura, K; Iwadate, Y; Kawauchi, D; Kobayashi, T; Narita, Y; Satomi, K; Takahashi, M; Tomiyama, A; Uchida, E; Yamamuro, S1

Other Studies

2 other study(ies) available for temozolomide and ceritinib

ArticleYear
Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment.
    Journal of the neurological sciences, 2020, Nov-15, Volume: 418

    Topics: Antineoplastic Agents, Alkylating; Benzamides; Brain Neoplasms; Cell Line, Tumor; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Glioblastoma; Humans; Imidazoles; Pharmaceutical Preparations; Phosphatidylinositol 3-Kinases; Pyrimidines; Sulfones; Temozolomide; Triazines; Tumor Suppressor Proteins

2020
The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death.
    Cancer science, 2021, Volume: 112, Issue:6

    Topics: Administration, Oral; Anaplastic Lymphoma Kinase; Animals; Brain Neoplasms; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; STAT3 Transcription Factor; Sulfones; Temozolomide; Treatment Outcome; Xenograft Model Antitumor Assays

2021